Advisory Committees
-
May 7, 2010: Vaccines and Related Biological Products Advisory Committee Meeting Presentations
-
May 7, 2010: Vaccines and Related Biological Products Advisory Committee Meeting Presentations
May 7, 2010: Vaccines and Related Biological Products Advisory Committee Meeting Presentation: CBER Assessment of Porcine Circovirus in Vaccines (PPT - 1.4MB)
Philip R. Krause, M.D.May 7, 2010: Vaccines and Related Biological Products Advisory Committee Meeting: Detection of Porcine circovirus (PCV) and PCV DNA Sequences in U.S. Licensed Rotavirus Vaccines and the Use of Emerging Analytical Technologies for the Detection of Adventitious Agents in Vaccines (PPT - 137KB)
Norman W. Baylor, PhDMay 7, 2010: Vaccines and Related Biological Products Advisory Committee: Monitoring Safety of Rotavirus Vaccines (PPT - 173KB)
David Martin, MD, MPHMay 7, 2010: Vaccines and Related Biological Products Advisory Committee Meeting FDA’s Approach to Adventitious-Agent Testing of Cell Substrates and Viral Vaccines: Traditional and Novel Methods (PPT - 350KB)
Keith Peden
-
-
May 7, 2010 Vaccines and Related Biological Products Advisory Committee Meeting: Other Presentations
Persons with disabilities having problems accessing the PowerPoint file may call 301-827-0314 for assistance.
May 7, 2010: Vaccines and Related Biological Products Advisory Committee Meeting Presentations: Burden of Rotavirus Disease & Impact of Rotavirus Vaccination (PPTX - 7.3MB)
Umesh D. Parashar, MBBS, MPHMay 7, 2010: Vaccines and Related Biological Products Advisory Committee Meeting Presentations: Porcine Circovirus (PPT - 24.6MB)
Dr Gordon Allan and Dr Steve KrakowkaMay 7, 2010: Vaccines and Related Biological Products Advisory Committee Meeting: ROTARIX (Rotavirus Vaccine, Live Oral): GSK’s PCV1 Investigation (PPTX - 2.4MB)
Barbara Howe, MD
-
-
-







